Followers | 829 |
Posts | 119659 |
Boards Moderated | 16 |
Alias Born | 09/05/2002 |
Thursday, February 22, 2024 4:24:30 PM
https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0001706431/000162828024006346/vir-20240221.htm
This outcome is not surprising outcome insofar as the phase-2 trial of VIR-2484, the lead compound of the collaboration, was a failure ( #msg-172395320).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent VIR News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/14/2024 08:05:39 PM
- Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results • Business Wire • 05/02/2024 08:05:00 PM
- Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024 • Business Wire • 04/30/2024 08:05:00 PM
- Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors • Business Wire • 04/18/2024 12:00:00 PM
- Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 • Business Wire • 04/11/2024 08:30:00 PM
- Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule • Business Wire • 03/05/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:34:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:32:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:32:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 12:31:36 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2024 09:27:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2024 09:10:13 PM
- Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences • Business Wire • 02/23/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:12:49 PM
- Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/22/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:33:11 PM
- Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer • Business Wire • 02/20/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:56:49 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:00:42 PM
- Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024 • Business Wire • 02/01/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 07:47:59 PM
- Apple Stocks Reach Record, Adobe Faces Stock Drops, Berkshire Hathaway Increases Stake in OXY, and More • IH Market News • 12/14/2023 10:59:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 09:06:03 PM
- Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation • Business Wire • 12/13/2023 09:05:00 PM
- Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference • Business Wire • 12/06/2023 09:05:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM